122 related articles for article (PubMed ID: 12859994)
21. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
[TBL] [Abstract][Full Text] [Related]
22. Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment.
Lista P; Brizzi MF; Rossi M; Resegotti L; Clark SC; Pegoraro L
Br J Haematol; 1990 Sep; 76(1):21-6. PubMed ID: 2223644
[TBL] [Abstract][Full Text] [Related]
23. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
Nagata K; Tohda S; Suzuki T; Nara N
Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
[TBL] [Abstract][Full Text] [Related]
25. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
[TBL] [Abstract][Full Text] [Related]
27. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
Curtis JE; Minkin S; Minden MD; McCulloch EA
Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892
[TBL] [Abstract][Full Text] [Related]
28. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic Growth Factors and Blast Progenitors in Acute Leukemia.
Miyauchi J
Hematology; 1997; 2(6):435-58. PubMed ID: 27415841
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human granulocyte colony-stimulating factor in combination with continuous infusion of cytosine arabinoside for the treatment of refractory acute myelogenous leukemia.
Goto H; Shimazaki C; Hirata T; Ashihara E; Ohkawa K; Oku N; Inaba T; Fujita N; Nakagawa M
Acta Haematol; 1993; 89(3):144-8. PubMed ID: 7689779
[TBL] [Abstract][Full Text] [Related]
31. High-dose cytosine arabinoside in the treatment of acute myelogenous leukemia: contributions to outcome of clinical and laboratory attributes.
Curtis JE; Messner HA; Minden MD; Minkin S; McCulloch EA
J Clin Oncol; 1987 Apr; 5(4):532-43. PubMed ID: 3549988
[TBL] [Abstract][Full Text] [Related]
32. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
33. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
[TBL] [Abstract][Full Text] [Related]
34. Haemopoietic growth factors, the cell cycle of acute myeloblastic leukaemia progenitors and sensitivity to cytosine arabinoside.
Smith MA; Smith JG; Pallister CJ; Singer CR
Leuk Lymphoma; 1996 Nov; 23(5-6):467-72. PubMed ID: 9031077
[TBL] [Abstract][Full Text] [Related]
35. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins.
Konopleva M; Tari AM; Estrov Z; Harris D; Xie Z; Zhao S; López-Berestein G; Andreeff M
Blood; 2000 Jun; 95(12):3929-38. PubMed ID: 10845930
[TBL] [Abstract][Full Text] [Related]
36. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
Gotoh A; Kawanishi Y; Kurosawa K; Miyazawa K; Ohtaka M; Aizawa S; Kimura Y; Yoshikawa O; Toyama K
Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660
[TBL] [Abstract][Full Text] [Related]
37. Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D.
Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
Leuk Res; 1985; 9(8):1059-67. PubMed ID: 3862923
[TBL] [Abstract][Full Text] [Related]
38. [The effect of interferon alone, cytosine arabinoside alone and their combined effect on hematopoietic progenitors of chronic myeloid leukemia in vitro].
Qin H; Yang Y; Liang Y; Li Y; Zeng L
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):281-4. PubMed ID: 12575210
[TBL] [Abstract][Full Text] [Related]
39. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
[TBL] [Abstract][Full Text] [Related]
40. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
